Slate Path Capital LP Organon & Co. Transaction History
Slate Path Capital LP
- $6.33 Billion
- Q3 2024
A detailed history of Slate Path Capital LP transactions in Organon & Co. stock. As of the latest transaction made, Slate Path Capital LP holds 2,463,963 shares of OGN stock, worth $35.9 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
2,463,963
Previous 5,393,786
54.32%
Holding current value
$35.9 Million
Previous $112 Million
57.78%
% of portfolio
0.74%
Previous 2.19%
Shares
6 transactions
Others Institutions Holding OGN
# of Institutions
793Shares Held
192MCall Options Held
1.71MPut Options Held
865K-
Black Rock Inc. New York, NY32.6MShares$475 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$440 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.76MShares$142 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$131 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.49MShares$109 Million0.31% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.71B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...